As of 2025-05-24, the Relative Valuation of PTC Therapeutics Inc (PTCT) is 139.15 USD. This relative valuation is based on P/E multiples. With the latest stock price at 45.93 USD, the upside of PTC Therapeutics Inc based on Relative Valuation is 203.0%.
The range of the Relative Valuation is 109.36 - 183.72 USD.
| Range | Selected | |
| Trailing P/E multiples | 15.8x - 24.4x | 20.2x |
| Forward P/E multiples | 14.5x - 19.8x | 16.6x |
| Fair Price | 109.36 - 183.72 | 139.15 |
| Upside | 138.1% - 300.0% | 203.0% |
| Date | P/E |
| 2025-05-16 | 6.10 |
| 2025-05-15 | 6.01 |
| 2025-05-14 | 6.20 |
| 2025-05-13 | 6.15 |
| 2025-05-12 | 6.10 |
| 2025-05-09 | 5.86 |
| 2025-05-08 | 5.64 |
| 2025-05-07 | 5.40 |
| 2025-05-06 | 4.80 |
| 2025-05-05 | 5.39 |
| 2025-05-02 | 6.62 |
| 2025-05-01 | 6.57 |
| 2025-04-30 | 6.61 |
| 2025-04-29 | 6.57 |
| 2025-04-28 | 6.60 |
| 2025-04-25 | 6.57 |
| 2025-04-24 | 6.57 |
| 2025-04-23 | 6.62 |
| 2025-04-22 | 6.39 |
| 2025-04-21 | 6.39 |
| 2025-04-17 | 6.28 |
| 2025-04-16 | 6.15 |
| 2025-04-15 | 6.22 |
| 2025-04-14 | 5.98 |
| 2025-04-11 | 5.70 |
| 2025-04-10 | 5.34 |
| 2025-04-09 | 5.67 |
| 2025-04-08 | 5.27 |
| 2025-04-07 | 5.68 |
| 2025-04-04 | 5.73 |
| 2025-04-03 | 6.20 |
| 2025-04-02 | 6.41 |
| 2025-04-01 | 6.18 |
| 2025-03-31 | 6.76 |
| 2025-03-28 | 7.19 |
| 2025-03-27 | 7.29 |
| 2025-03-26 | 7.33 |
| 2025-03-25 | 7.46 |
| 2025-03-24 | 7.56 |
| 2025-03-21 | 7.58 |
| 2025-03-20 | 7.51 |
| 2025-03-19 | 7.55 |
| 2025-03-18 | 7.35 |
| 2025-03-17 | 7.58 |
| 2025-03-14 | 7.23 |
| 2025-03-13 | 7.00 |
| 2025-03-12 | 7.11 |
| 2025-03-11 | 6.97 |
| 2025-03-10 | 6.96 |
| 2025-03-07 | 6.97 |